BST-CarGel: Phase III data

An international, blinded Phase III trial in 80 patients aged 18-55 with single symptomatic grade III/IV focal lesions on

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE